Adolfo García-Sastre to Humans
This is a "connection" page, showing publications Adolfo García-Sastre has written about Humans.
Connection Strength
0.147
-
Immunological imprinting of the antibody response in COVID-19 patients. Nat Commun. 2021 06 18; 12(1):3781.
Score: 0.008
-
Plitidepsin has potent preclinical efficacy against SARS-CoV-2 by targeting the host protein eEF1A. Science. 2021 02 26; 371(6532):926-931.
Score: 0.007
-
SARS-CoV-2 Orf6 hijacks Nup98 to block STAT nuclear import and antagonize interferon signaling. Proc Natl Acad Sci U S A. 2020 11 10; 117(45):28344-28354.
Score: 0.007
-
An Immunocompetent Mouse Model of Zika Virus Infection. Cell Host Microbe. 2018 05 09; 23(5):672-685.e6.
Score: 0.006
-
Specific Mutations in the PB2 Protein of Influenza A Virus Compensate for the Lack of Efficient Interferon Antagonism of the NS1 Protein of Bat Influenza A-Like Viruses. J Virol. 2018 04 01; 92(7).
Score: 0.006
-
Ten Strategies of Interferon Evasion by Viruses. Cell Host Microbe. 2017 Aug 09; 22(2):176-184.
Score: 0.006
-
Antagonism of type I interferon by flaviviruses. Biochem Biophys Res Commun. 2017 10 28; 492(4):587-596.
Score: 0.006
-
Inactivated influenza virus vaccines: the future of TIV and QIV. Curr Opin Virol. 2017 04; 23:102-106.
Score: 0.006
-
2 methylate or not 2 methylate: viral evasion of the type I interferon response. Nat Immunol. 2011 Feb; 12(2):114-5.
Score: 0.004
-
A household case evidences shorter shedding of SARS-CoV-2 in naturally infected cats compared to their human owners. Emerg Microbes Infect. 2021 Dec; 10(1):376-383.
Score: 0.002
-
Contribution of SARS-CoV-2 Accessory Proteins to Viral Pathogenicity in K18 Human ACE2 Transgenic Mice. J Virol. 2021 08 10; 95(17):e0040221.
Score: 0.002
-
Longitudinal metabolomics of human plasma reveals prognostic markers of COVID-19 disease severity. Cell Rep Med. 2021 08 17; 2(8):100369.
Score: 0.002
-
After the pandemic: perspectives on the future trajectory of COVID-19. Nature. 2021 08; 596(7873):495-504.
Score: 0.002
-
Drug-induced phospholipidosis confounds drug repurposing for SARS-CoV-2. Science. 2021 07 30; 373(6554):541-547.
Score: 0.002
-
Transcriptomics-based drug repositioning pipeline identifies therapeutic candidates for COVID-19. Sci Rep. 2021 06 10; 11(1):12310.
Score: 0.002
-
Control of Innate Immune Activation by Severe Acute Respiratory Syndrome Coronavirus 2 and Other Coronaviruses. J Interferon Cytokine Res. 2021 06; 41(6):205-219.
Score: 0.002
-
Tissue-based SARS-CoV-2 detection in fatal COVID-19 infections: Sustained direct viral-induced damage is not necessary to drive disease progression. Hum Pathol. 2021 08; 114:110-119.
Score: 0.002
-
Hepatitis C virus drugs that inhibit SARS-CoV-2 papain-like protease synergize with remdesivir to suppress viral replication in cell culture. Cell Rep. 2021 05 18; 35(7):109133.
Score: 0.002
-
Functional landscape of SARS-CoV-2 cellular restriction. Mol Cell. 2021 06 17; 81(12):2656-2668.e8.
Score: 0.002
-
Pathophysiology of SARS-CoV-2: the Mount Sinai COVID-19 autopsy experience. Mod Pathol. 2021 08; 34(8):1456-1467.
Score: 0.002
-
TOP1 inhibition therapy protects against SARS-CoV-2-induced lethal inflammation. Cell. 2021 05 13; 184(10):2618-2632.e17.
Score: 0.002
-
Sterilizing Immunity against SARS-CoV-2 Infection in Mice by a Single-Shot and Lipid Amphiphile Imidazoquinoline TLR7/8 Agonist-Adjuvanted Recombinant Spike Protein Vaccine*. Angew Chem Int Ed Engl. 2021 04 19; 60(17):9467-9473.
Score: 0.002
-
Intestinal Host Response to SARS-CoV-2 Infection and COVID-19 Outcomes in Patients With Gastrointestinal Symptoms. Gastroenterology. 2021 06; 160(7):2435-2450.e34.
Score: 0.002
-
Nsp1 protein of SARS-CoV-2 disrupts the mRNA export machinery to inhibit host gene expression. Sci Adv. 2021 02; 7(6).
Score: 0.002
-
MDA5 Governs the Innate Immune Response to SARS-CoV-2 in Lung Epithelial Cells. Cell Rep. 2021 01 12; 34(2):108628.
Score: 0.002
-
Comparison of transgenic and adenovirus hACE2 mouse models for SARS-CoV-2 infection. Emerg Microbes Infect. 2020 Dec; 9(1):2433-2445.
Score: 0.002
-
Shedding of Viable SARS-CoV-2 after Immunosuppressive Therapy for Cancer. N Engl J Med. 2020 12 24; 383(26):2586-2588.
Score: 0.002
-
An ultrapotent synthetic nanobody neutralizes SARS-CoV-2 by stabilizing inactive Spike. Science. 2020 12 18; 370(6523):1473-1479.
Score: 0.002
-
Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. Science. 2020 12 04; 370(6521).
Score: 0.002
-
Inborn errors of type I IFN immunity in patients with life-threatening COVID-19. Science. 2020 10 23; 370(6515).
Score: 0.002
-
Animal models for COVID-19. Nature. 2020 10; 586(7830):509-515.
Score: 0.002
-
Current Status of COVID-19 (Pre)Clinical Vaccine Development. Angew Chem Int Ed Engl. 2020 10 19; 59(43):18885-18897.
Score: 0.002
-
An In Vitro Microneutralization Assay for SARS-CoV-2 Serology and Drug Screening. Curr Protoc Microbiol. 2020 09; 58(1):e108.
Score: 0.002
-
Discovery of SARS-CoV-2 antiviral drugs through large-scale compound repurposing. Nature. 2020 10; 586(7827):113-119.
Score: 0.002
-
The Global Phosphorylation Landscape of SARS-CoV-2 Infection. Cell. 2020 08 06; 182(3):685-712.e19.
Score: 0.002
-
Coronavirus disease 2019 (COVID-19) hospitalized patients with acute kidney injury treated with acute peritoneal dialysis do not have infectious peritoneal dialysis effluent. Kidney Int. 2020 09; 98(3):782.
Score: 0.002
-
Introductions and early spread of SARS-CoV-2 in the New York City area. Science. 2020 07 17; 369(6501):297-301.
Score: 0.002
-
A serological assay to detect SARS-CoV-2 seroconversion in humans. Nat Med. 2020 07; 26(7):1033-1036.
Score: 0.002
-
A SARS-CoV-2 protein interaction map reveals targets for drug repurposing. Nature. 2020 07; 583(7816):459-468.
Score: 0.002
-
Sequential Immunization With Live-Attenuated Chimeric Hemagglutinin-Based Vaccines Confers Heterosubtypic Immunity Against Influenza A Viruses in a Preclinical Ferret Model. Front Immunol. 2019; 10:756.
Score: 0.002
-
Influenza Virus NS1 Protein-RNA Interactome Reveals Intron Targeting. J Virol. 2018 12 15; 92(24).
Score: 0.002
-
Influenza virus infection causes global RNAPII termination defects. Nat Struct Mol Biol. 2018 09; 25(9):885-893.
Score: 0.002
-
Transcription Elongation Can Affect Genome 3D Structure. Cell. 2018 09 06; 174(6):1522-1536.e22.
Score: 0.002
-
Is It Possible to Develop a "Universal" Influenza Virus Vaccine? Potential Target Antigens and Critical Aspects for a Universal Influenza Vaccine. Cold Spring Harb Perspect Biol. 2018 07 02; 10(7).
Score: 0.002
-
Innate immune sensor LGP2 is cleaved by the Leader protease of foot-and-mouth disease virus. PLoS Pathog. 2018 06; 14(6):e1007135.
Score: 0.002
-
Co-regulatory activity of hnRNP K and NS1-BP in influenza and human mRNA splicing. Nat Commun. 2018 06 19; 9(1):2407.
Score: 0.002
-
Paramyxovirus V Proteins Interact with the RIG-I/TRIM25 Regulatory Complex and Inhibit RIG-I Signaling. J Virol. 2018 03 15; 92(6).
Score: 0.002
-
SMARCA2-regulated host cell factors are required for MxA restriction of influenza A viruses. Sci Rep. 2018 02 01; 8(1):2092.
Score: 0.002
-
MERS-CoV 4b protein interferes with the NF-?B-dependent innate immune response during infection. PLoS Pathog. 2018 01; 14(1):e1006838.
Score: 0.002
-
Pandemic H1N1 influenza A viruses suppress immunogenic RIPK3-driven dendritic cell death. Nat Commun. 2017 12 05; 8(1):1931.
Score: 0.001
-
Single-cell analysis of early antiviral gene expression reveals a determinant of stochastic IFNB1 expression. Integr Biol (Camb). 2017 Nov 13; 9(11):857-867.
Score: 0.001
-
Influenza virus differentially activates mTORC1 and mTORC2 signaling to maximize late stage replication. PLoS Pathog. 2017 Sep; 13(9):e1006635.
Score: 0.001
-
Human interactome of the influenza B virus NS1 protein. J Gen Virol. 2017 Sep; 98(9):2267-2273.
Score: 0.001
-
Loss of Sendai virus C protein leads to accumulation of RIG-I immunostimulatory defective interfering RNA. J Gen Virol. 2017 Jun; 98(6):1282-1293.
Score: 0.001
-
The RNA Exosome Syncs IAV-RNAPII Transcription to Promote Viral Ribogenesis and Infectivity. Cell. 2017 05 04; 169(4):679-692.e14.
Score: 0.001
-
Enhancement of Zika virus pathogenesis by preexisting antiflavivirus immunity. Science. 2017 04 14; 356(6334):175-180.
Score: 0.001
-
Dengue virus NS2B protein targets cGAS for degradation and prevents mitochondrial DNA sensing during infection. Nat Microbiol. 2017 Mar 27; 2:17037.
Score: 0.001
-
Systems-based analysis of RIG-I-dependent signalling identifies KHSRP as an inhibitor of RIG-I receptor activation. Nat Microbiol. 2017 Mar 01; 2:17022.
Score: 0.001
-
Defining the antibody cross-reactome directed against the influenza virus surface glycoproteins. Nat Immunol. 2017 04; 18(4):464-473.
Score: 0.001
-
Influenza virus exploits tunneling nanotubes for cell-to-cell spread. Sci Rep. 2017 01 06; 7:40360.
Score: 0.001
-
Influenza-infected neutrophils within the infected lungs act as antigen presenting cells for anti-viral CD8(+) T cells. PLoS One. 2012; 7(10):e46581.
Score: 0.001
-
Suppression of the antiviral response by an influenza histone mimic. Nature. 2012 Mar 14; 483(7390):428-33.
Score: 0.001
-
Structural basis for the removal of ubiquitin and interferon-stimulated gene 15 by a viral ovarian tumor domain-containing protease. Proc Natl Acad Sci U S A. 2011 Feb 08; 108(6):2222-7.
Score: 0.001
-
Interferon priming enables cells to partially overturn the SARS coronavirus-induced block in innate immune activation. J Gen Virol. 2009 Nov; 90(Pt 11):2686-2694.
Score: 0.001
-
Inhibition of the type I interferon response by the nucleoprotein of the prototypic arenavirus lymphocytic choriomeningitis virus. J Virol. 2006 Sep; 80(18):9192-9.
Score: 0.001